Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
$1.99
per week
for 24 weeks
// //

Abbvie Inc NYSE: ABBV-N

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 109.08
Day High 109.96
Open:109.15
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.

Fundamentals

Market Capitalization, $K
Shares Outstanding, K
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Strong Buy

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Active Psoriatic Arthritis in the European Union (EU)
- PR Newswire - PRF - Fri Oct 15, 7:35AM CDT
PR Newswire - PRF - CMTX
Fri Oct 15, 7:35AM CDT
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of risankizumab (SKYRIZI, 150 mg, subcutaneous injection at week 0, week 4 and every 12 weeks thereafter) alone or in combination with methotrexate (MTX), for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (DMARDs). The CHMP positive opinion is a scientific recommendation for marketing authorization to the European Commission, which authorizes marketing approval in the European Union.
Antiretroviral Protease Inhibitors Market Top Companies, Business Growth, Size and Forecast 2028
- AmericaNewsHour - Wed Oct 13, 1:02PM CDT
AmericaNewsHour - CMTX
Wed Oct 13, 1:02PM CDT
Research Nester published a report titled ": Global Demand Analysis & Opportunity Outlook 2028" which delivers detailed overview of the global antiretroviral protease inhibitors market in terms of market segmentation by mechanism of action, disease indication, distribution channel, end-user, and by region.
Dementia and Alzheimer's Disease Treatment Market Grow with a High CAGR Global Industry Analysis, And Key Players 2027
- AmericaNewsHour - Tue Oct 12, 9:37AM CDT
AmericaNewsHour - CMTX
Tue Oct 12, 9:37AM CDT
Research Nester released a report titled ": Global Demand Analysis & Opportunity Outlook 2028"which delivers detailed overview of the global dementia and Alzheimer's disease treatment market in terms of market segmentation by drug class, by distribution channel, and by region.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 105.56 +3.57% increase
on 09/20/21
Period Open:107.77
Price movement based on the high, low and last over the given period.
111.79 -2.20% decrease
on 10/07/21
+1.56 (+1.45%) increase
since 09/15/21
3-Month 105.56 +3.57% increase
on 09/20/21
Period Open:117.18
Price movement based on the high, low and last over the given period.
121.53 -10.04% decrease
on 09/01/21
-7.85 (-6.70%) decrease
since 07/15/21
52-Week 79.11 +38.20% increase
on 10/29/20
Period Open:85.23
Price movement based on the high, low and last over the given period.
121.53 -10.04% decrease
on 09/01/21
+24.10 (+28.28%) increase
since 10/15/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies